The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells

Cisplatin (DDP) resistance has become the leading cause of mortality in non-small cell lung cancer (NSCLC). miRNA dysregulation significantly contributes to tumor progression. In this study, we found that miR-495 was significantly downregulated in lung cancer tissue specimens. This study aimed to el...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiwei, Jin, Dan, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Miao, Shuang, Xi, Sichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419862/
https://www.ncbi.nlm.nih.gov/pubmed/30146342
http://dx.doi.org/10.1016/j.ebiom.2018.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419862/
https://www.ncbi.nlm.nih.gov/pubmed/30146342
http://dx.doi.org/10.1016/j.ebiom.2018.08.001

Ejemplares similares